Chemocentryx Inc. buy marge
Start price
21.06.15
/
50%
€7.75
Target price
21.12.15
€9.80
Performance (%)
-10.29%
End price
21.12.15
€6.95
Summary
This prediction ended on 21.12.15 with a price of €6.95. The price of Chemocentryx Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.29%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Chemocentryx Inc. | - | - | - | - |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% | 68.627% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% | 116.238% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% | 56.217% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% | 70.924% |
Comments by marge for this prediction
In the thread Chemocentryx Inc. diskutieren
Chemocentryx Inc.
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)